123 related articles for article (PubMed ID: 16312564)
1. Side effects of treatment with antimony salts.
Malta R; Affronti M; Di Rosa S; Vassallo L; Renda M; Trifirò G; Rubino ME; Rini GB
J Chemother; 1989 Jul; 1(4 Suppl):628-9. PubMed ID: 16312564
[No Abstract] [Full Text] [Related]
2. Meglumine antimoniate-induced pancreatitis.
Torrús D; Massa B; Boix V; Portilla J; Pérez-Mateo M
Am J Gastroenterol; 1996 Apr; 91(4):820-1. PubMed ID: 8677970
[No Abstract] [Full Text] [Related]
3. Cytogenetic observations after meglumine antimoniate therapy for visceral leishmaniasis.
Hantson P; Léonard ED; Crutzen-Fayt MC; Léonard A; Vandercam B; Delaere B; Mahieu P
Pharmacotherapy; 1996; 16(5):869-71. PubMed ID: 8888081
[TBL] [Abstract][Full Text] [Related]
4. [Nephrotic syndrome and acute pancreatitis related to glucantime administration].
Valencia ME; Laguna F; González Lahoz J
An Med Interna; 2000 Jan; 17(1):54. PubMed ID: 10730416
[No Abstract] [Full Text] [Related]
5. [Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].
Santos J; Rivero A; Márquez M
An Med Interna; 2000 Oct; 17(10):562-3. PubMed ID: 11109659
[No Abstract] [Full Text] [Related]
6. [Acute pancreatitis during treatment with meglumine antimoniate (Glucantime)].
Barthet M; Brunet P; Bernard JC; Dussol B; Rodor F; Jouglard J; Berland Y; Sahel J
Gastroenterol Clin Biol; 1994; 18(1):90-2. PubMed ID: 8187998
[No Abstract] [Full Text] [Related]
7. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.
de Lalla F; Pellizzer G; Gradoni L; Vespignani M; Franzetti M; Stecca C
Clin Infect Dis; 1993 May; 16(5):730-1. PubMed ID: 8507769
[No Abstract] [Full Text] [Related]
8. Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil.
Oliveira AL; Brustoloni YM; Fernandes TD; Dorval ME; Cunha RV; Bóia MN
Trop Doct; 2009 Jul; 39(3):180-2. PubMed ID: 19535762
[TBL] [Abstract][Full Text] [Related]
9. [N-methyl glucamine antimoniate or Glucantime].
Rapp C; Simon F; Dordain ML
Med Trop (Mars); 2000; 60(4):342-3. PubMed ID: 11436584
[No Abstract] [Full Text] [Related]
10. Severe leucopenia during treatment of visceral leishmaniasis.
Hiçsönmez G; Jama H; Ozsoylu S
Trans R Soc Trop Med Hyg; 1988; 82(3):417. PubMed ID: 3232176
[No Abstract] [Full Text] [Related]
11. Visceral leishmaniasis and disseminated intravascular coagulation in a dog.
Font A; Gines C; Closa JM; Mascort J
J Am Vet Med Assoc; 1994 Apr; 204(7):1043-4. PubMed ID: 8045804
[TBL] [Abstract][Full Text] [Related]
12. [Agranulocytosis caused by glucantime (N-methylglucamine antimoniate) during treatment of kala-azar].
Gutiérrez Rodero F; Moya Jeromini I; Ortiz de la Tabla Ducasse V; Pozuelo González A
Med Clin (Barc); 1985 May; 84(20):840. PubMed ID: 4033266
[No Abstract] [Full Text] [Related]
13. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
Cascio A; Colomba C; Antinori S; Orobello M; Paterson D; Titone L
Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):277-82. PubMed ID: 12072938
[TBL] [Abstract][Full Text] [Related]
14. [Agranulocytosis caused by glucantime in the treatment of kala-azar].
Gutiérrez Rodero F
Med Clin (Barc); 1986 Mar; 86(10):437. PubMed ID: 3713304
[No Abstract] [Full Text] [Related]
15. Acute pancreatitis caused by meglumine antimoniate given for the treatment of visceral leishmaniasis.
Lambertucci JR; França BM; Queiroz Ede M
Rev Soc Bras Med Trop; 2004; 37(1):74-5. PubMed ID: 15042193
[No Abstract] [Full Text] [Related]
16. [Symptomatic hypokalemia caused by meglumine antimoniate].
Bouvresse S; Matichard E; Mahé E; Marinho E; Soria A; Devillière M; Descamps V; Crickx B
Ann Dermatol Venereol; 2007 Apr; 134(4 Pt 1):387-8. PubMed ID: 17483764
[No Abstract] [Full Text] [Related]
17. Kala-azar in Afghanistan.
Singh M; Arya LS; Aram GN; Fazal MI; Qureshi MA; Goel RG
J Trop Med Hyg; 1982 Oct; 85(5):201-4. PubMed ID: 7176002
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of imported mucosal Leishmania infantum leishmaniasis with miltefosine after severe hypokalemia under meglumine antimoniate treatment.
Neumayr AL; Walter C; Stoeckle M; Braendle N; Glatz K; Blum JA
J Travel Med; 2012; 19(2):124-6. PubMed ID: 22414039
[TBL] [Abstract][Full Text] [Related]
19. Pentavalent antimonial-induced torsade de pointes.
Ortega-Carnicer J; Alcázar R; De la Torre M; Benezet J
J Electrocardiol; 1997 Apr; 30(2):143-5. PubMed ID: 9141610
[TBL] [Abstract][Full Text] [Related]
20. Antimony containing drug and ECG abnormalities in children with visceral leishmaniasis.
Zanoni LZ; Brustoloni YM; Melnikov P; Cônsolo CE
Biol Trace Elem Res; 2009 Dec; 132(1-3):35-40. PubMed ID: 19424667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
